Importantly, when CARs were exposed for long periods to tumor cells in vitro and subsequently used for in vivo experiments, the GD2-B7H3 T cells demonstrated superior anti-tumor efficacy to conventional B7H3 CARs. The gene discussed is CD276; the disease is neoplasm.